Rolf K. Hoffmann - 16 Feb 2022 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Role: Director
Signature: /s/ William M. Haskel, Attorney-in-Fact for Rolf K. Hoffmann
Issuer symbol: N/A
Transactions as of: 16 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Feb 2022, 16:23:41 UTC
Next filing: 09 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTK	Common Stock	Award	$0	+20,000	+45%	$0.000000	64,000	16 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 16, 2022, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Content

Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 16, 2022, subject to the Reporting Person's continued service with the Issuer through the vesting date.